Tuesday, October 19, 2021
2:00 PM - 3:00 PM (ET)
Join a conversation about how increased computational power and new capabilities in genetic engineering will impact our future. JAX CEO and President Edison Liu, M.D. will discuss how these exceedingly powerful technologies require careful and thoughtful management to maximize benefit and to minimize harm. Liu will share his experiences with the now (The Jackson Laboratory), the national (NIH), and the global (Genome Institute of Singapore, Human Genome Organization), with a focus on how informed citizenry is needed to govern these complex email@example.com.
Edison Liu, M.D., is the president and CEO of The Jackson Laboratory, an independent research institute focused on complex genetics and functional genomics with campuses in Maine, Connecticut, and California. He is also the Director of the NCI designated JAX Cancer Center. Previously, he was the founding executive director of the Genome Institute of Singapore and the president of the Human Genome Organization (HUGO). He was also the scientific director of the National Cancer Institute's Division of Clinical Sciences in Bethesda, Md., where he was in charge of the intramural clinical translational science programs. In his earlier career, Dr. Liu was a faculty member at the University of North Carolina at Chapel Hill, where he was the director of the UNC Lineberger Comprehensive Cancer Center's Specialized Program of Research Excellence in Breast Cancer; the director of the Laboratory of Molecular Epidemiology at UNC's School of Public Health; and the Chief of Medical Genetics. Dr. Liu is an international expert in cancer biology, systems genomics, human genetics, molecular epidemiology and translational medicine. Dr. Liu's own scientific research has focused on the functional genomics of human cancers, particularly breast cancer, uncovering new oncogenes, and deciphering on a genomic scale the dynamics of gene regulation that modulate cancer biology. He has authored over 320 scientific papers and reviews and co-authored two books. He obtained his B.S. in chemistry and psychology, as well as his M.D., at Stanford University. He then received his residency and fellowship training at Washington University, St, Louis, and Stanford, and post-doctoral training in molecular oncology at the University of California at San Francisco.
Bryan Robinson, Ph.D., M.A., serves on the senior management team as the vice president for advancement, leading the development and advancement operations efforts for the purpose of increasing philanthropic support for the Laboratory’s mission. Based in Bar Harbor, Maine, the advancement team works within a domestic and international strategy in seeking and cultivating relationships for JAX.
Prior to arriving at the Laboratory, Bryan previously served as the president of the UNCP Foundation in North Carolina, and as the vice chancellor for advancement in The UNC System at UNC Pembroke. Prior to his appointment in North Carolina, Bryan served as the senior assistant vice president and interim vice president at the University of Louisville. Bryan also served in a senior director of development and campaign planning role at Indiana University; and as a state government appointee in Indiana, appointed by then Governor Mitch Daniels. Bryan and his teams have successfully completed multiple campaigns for health sciences and research-related centers and institutes in Indiana, Kentucky and North Carolina.
Bryan has an undergraduate degree in pre-law studies and a master’s degree in education administration, both from the University of Louisville. He holds a Ph.D. in education and social change from Bellarmine University, having also completed field research in London, UK at the University of Roehampton, where he studied the impact of poverty on child and youth development. Bryan is based in Bar Harbor, Maine.